terminalia chebula
Botanicalexperimental
Terminalia chebula, commonly known as black- or chebulic myrobalan, is a species of Terminalia, native to South Asia from Pakistan, India and Nepal east to southwest China (Yunnan), and south to Sri Lanka, Malaysia, and Vietnam. — Wikipedia
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2015 (NCT02589249)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaTerminalia chebula ↗
Also known as
- terminalia chebula
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04597502 | N/A | Oct 15, 2020 | Integrative Skin Science and Research, Sytheon Ltd. |
| NCT04276753 | N/A | Feb 19, 2020 | Sytheon Ltd. |
| NCT02589249 | N/A | Nov 1, 2015 | Natreon, Inc., The Center for Applied Health Sciences, LLC |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sytheon Ltd. | For profit | 2 | 1 | 1 | 2020 |
| Integrative Skin Science and Research | For profit | 1 | 1 | 1 | 2020 |
| Natreon, Inc. | For profit | 1 | 0 | 1 | 2015 |
| The Center for Applied Health Sciences, LLC | Academic/Hospital | 1 | 1 | 1 | 2015 |
4 organizations
Page 1 / 1